Lupin bags tentative USFDA nod for Dapagliflozin and Saxagliptin Tablets Ruchika Sharma5 Jan 2024 11:11 AM ISTDapagliflozin and Saxagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes...
CDSCO Panel Grants AstraZeneca's Protocol Amendment Proposal for Anifrolumab Dr. Divya Colin4 Jan 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation CDSO has approved the drug major's...
Esperion, Daiichi Sankyo Europe announce USD 125 million amendment to their collaboration, including resolution of pending litigation Ruchika Sharma4 Jan 2024 4:45 PM ISTAnn Arbor: Esperion Therapeutics, Inc. and Daiichi Sankyo Europe GmbH (DSE), the European headquarter organization of the Japanese pharmaceutical...
Natco Pharma concludes transition of DASH Pharma into Natco Pharma USA Ruchika Sharma4 Jan 2024 3:42 PM ISTParsippany: Natco Pharma Limited, a research and development (R&D)-focused pharmaceutical company based in India, has announced that DASH...
Bristol Myers Squibb Repotrectinib application to treat cancer validated by EMA Ruchika Sharma4 Jan 2024 1:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its marketing authorization application...
CVS Health to remove AbbVie rheumatoid arthritis drug Humira from some drug reimbursement lists in April Ruchika Sharma4 Jan 2024 12:30 PM ISTA CVS spokesperson said the company expects most of its customers to transition their coverage to biosimilars of Humira, known chemically as...
Pfizer gene therapy for bleeding disorder approved in Canada Ruchika Sharma4 Jan 2024 11:51 AM ISTCanada: Pfizer said on Wednesday that Canada's health regulator approved its gene therapy for the treatment of a rare inherited bleeding...
Guselkumab tied with early improvement in psoriasis associated arthritis Dr. Shravani Dali4 Jan 2024 7:45 AM ISTGuselkumab associated with early improvement of joints and reduced progression of psoriatic arthritis suggests a new study published in the Clinical...
Trastuzumab deruxtecan: AstraZeneca India Pharma unveils HER-2 positive metastatic breast cancer therapy Ruchika Sharma3 Jan 2024 3:59 PM ISTNew Delhi: AstraZeneca India Pharma Ltd., a science-led biopharmaceutical company officially launched Trastuzumab deruxtecan, therapy tailored...
USFDA approvals bounce back in 2023, sparking hopes of biotech recovery Ruchika Sharma3 Jan 2024 3:22 PM ISTThe U.S. Food and Drug Administration approved nearly 50% more novel drugs in 2023 than in 2022, putting it back on pace with historical levels, an...
Voyager Therapeutics enters Capsid license agreement with Novartis to advance novel gene therapies Ruchika Sharma3 Jan 2024 2:37 PM ISTUnder the terms of the agreement, Novartis has agreed to pay Voyager $100 million of consideration up front, including a $20 million purchase of newly...
Boehringer Ingelheim partners with Ribo to develop new treatments for people with liver diseases Ruchika Sharma3 Jan 2024 1:53 PM ISTIngelheim: Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo) have announced a collaboration with Boehringer Ingelheim to...
